CHOC’s study published in the Pediatrics journal finds that though COVID-19 infections in newborns are rare, they may cause severe disease.
New clinic and study site for patients with rare syndrome Fragile X opens in Thompson Autism and Neurodevelopmental Center
The Fragile X Clinic at CHOC will be devoted to the diagnosis, treatment, and study of the rare genetic condition of Fragile X syndrome.
CHOC conducts clinical trial for Glycogen Storage Disease type 1a
CHOC selected as West Coast site for gene therapy clinical trial for patients 8 years and older with Glycogen Storage Disease type 1a.
Mental health specialists value being embedded in primary care clinics
New CHOC study integrating mental health into primary care seeks patients to receive cognitive therapy and/or medication.
National leader in improving sepsis outcomes already making an impact after six months on the job
Dr. Raina Paul is making strides in quality-improvement science to better pediatric sepsis at CHOC’s emergency department.
Dr. Terrie Inder, incoming chair of Center of Neonatal Research at CHOC, is used to blazing trails
CHOC is thrilled to introduce neonatologist and child neurologist Dr. Terrie Inder to advance outcomes of neonatal-perinatal medicine.
